Posted from: Tuesday, November 05, 2013 - 05:44 PM - Present

Herpes and Chickenpox Treatment: Acyclovir Oral Suspension USP Recalled

On October 28, 2013, Hi-Tech Pharmacal, Co., Inc. issued a recall of Acyclovir Oral Suspension USP, 200 mg/5mL, due to unsatisfactory quality standards during testing.

The recalled lots are as follows:

Lot

Expiration Date

Lot

Expiration Date

614463

03/2014

612851

12/2013

612905

12/2013

614779

03/2014

614923

03/2014

615852

05/2014

615855

05/2014

616689

07/2014

616692

07/2014

618743

11/2014

613396

12/2013

 

 

The NDC affected is 50383-810-16.

Acyclovir is prescribed to treat the symptoms of herpes virus infections, including shingles (herpes zoster), and genital herpes.  Acyclovir also treats chickenpox.

Although no adverse health reactions have been associated with this recall, patients in possession of this product should contact the pharmacy or doctor’s office at which it was obtained.  If you have any questions about this recall please contact your local retail pharmacist or speak to your doctor.

Adverse events that may be related to the use of this product may also be reported to the United States Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting Program either online, by regular mail or by fax:

Online: www.fda.gov/medwatch/report.htm

Regular Mail: use postage-paid FDA form 3500 available at: www.fda.gov/MedWatch/getforms.htm.  Mail the form to: MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787

Fax: 1-800-FDA-0178

 

Last Updated Saturday, August 19, 2017 - 02:38 PM.